Firestein, G. S. Evolving ideas of rheumatoid arthritis. Nature 423, 356–361 (2003).
McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205–2219 (2011).
Burmester, G. R., Feist, E. & Dörner, T. Rising cell and cytokine targets in rheumatoid arthritis. Nat. Rev. Rheumatol. 10, 77–88 (2014).
Van Vollenhoven, R. F. Therapy of rheumatoid arthritis: state-of-the-art. Nat. Rev. Rheumatol. 5, 531–541 (2009).
Aletaha, D. & Smolen, J. S. Prognosis and administration of rheumatoid arthritis: a evaluation. JAMA 320, 1360–1372 (2018).
Zhu, Y. et al. Rheumatoid arthritis microenvironment insights into remedy impact of nanomaterials. Nano Right this moment 42, 101358 (2022).
Esensten, J. H., Wofsy, D. & Bluestone, J. A. Regulatory T cells as therapeutic targets in rheumatoid arthritis. Nat. Rev. Rheumatol. 5, 560–565 (2009).
Kim, J. et al. Synergistic oxygen era and reactive oxygen species scavenging by manganese ferrite/ceria Co-decorated nanoparticles for rheumatoid arthritis remedy. ACS Nano 13, 3206–3217 (2019).
Zhu, L. et al. TSC1 controls macrophage polarization to forestall inflammatory illness. Nat. Commun. 5, 4696 (2014).
Weyand, C. M. & Goronzy, J. J. Immunometabolism in early and late levels of rheumatoid arthritis. Nat. Rev. Immunol. 13, 291–301 (2017).
Yang, C. et al. Inorganic nanosheets facilitate humoral immunity towards medical implant infections by modulating immune co-stimulatory pathways. Nat. Commun. 13, 4866 (2022).
Wu, W. et al. Microbiotic nanomedicine for tumor-specific chemotherapy-synergized innate/adaptive antitumor immunity. Nano Right this moment 42, 101377 (2022).
McInnes, I. B. & Schett, G. Cytokines within the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7, 429–442 (2007).
Pelaz, B. et al. Numerous functions of nanomedicine. ACS Nano 11, 2313–2381 (2017).
Dominguez-Villar, M. & Hafler, D. A. Regulatory T cells in autoimmune illness. Nat. Immunol. 19, 665–673 (2018).
Komatsu, N. et al. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat. Med. 20, 62–68 (2014).
Kim, C. Ok. et al. Ceria nanoparticles that may shield towards ischemic stroke. Angew. Chem. Int. Ed. 51, 11039–11043 (2012).
Soh, M. et al. Ceria–zirconia nanoparticles as an enhanced multi-antioxidant for sepsis remedy. Angew. Chem. Int. Ed. 56, 11399–11403 (2017).
Nguyen, L., Bang, S. & Noh, I. Tissue regeneration of human mesenchymal stem cells on porous gelatin micro-carriers by long-term dynamic in vitro tradition. Tissue Eng. Regen. Med. 16, 19–28 (2019).
Jiang, W. & Xu, J. Immune modulation by mesenchymal stem cells. Cell Prolif. 53, e12712 (2022).
Suryaprakash, S. et al. Engineered mesenchymal stem cell/nanomedicine spheroid as an energetic drug supply platform for combinational glioblastoma remedy. Nano Lett. 19, 1701–1705 (2019).
Lu, Ok. et al. Low-dose X-ray radiotherapy–radiodynamic remedy through nanoscale metallic–natural frameworks enhances checkpoint blockade immunotherapy. Nat. Biomed. Eng. 2, 600–610 (2018).
Shahir, M. et al. Impact of mesenchymal stem cell‐derived exosomes on the induction of mouse tolerogenic dendritic cells. J. Cell. Physiol. 235, 7043–7055 (2020).
Gao, J., Gu, H. & Xu, B. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical functions. Acc. Chem. Res. 42, 1097–1107 (2009).
Pelaz, B. et al. Floor functionalization of nanoparticles with polyethylene glycol: results on protein adsorption and mobile uptake. ACS Nano 9, 6996–7008 (2015).
Koo, S. et al. Enhanced chemodynamic remedy by Cu–Fe peroxide nanoparticles: tumor microenvironment-mediated synergistic Fenton response. ACS Nano 16, 2535–2545 (2022).
Mittal, M. et al. Reactive oxygen species in irritation and tissue harm. Antioxid. Redox Sign. 20, 1126–1167 (2014).
Kemp, Ok. Mesenchymal stem cell‐secreted superoxide dismutase promotes cerebellar neuronal survival. J. Neurochem. 114, 1569–1580 (2010).
Uccelli, A., Moretta, L. & Pistoia, V. Mesenchymal stem cells in well being and illness. Nat. Rev. Immunol. 8, 726–736 (2008).
Adams, D. O. & Hamilton, T. A. The cell biology of macrophage activation. Annu. Rev. Immunol. 2, 283–318 (1984).
Richard, M. P. Apoptosis as a therapeutic software in rheumatoid arthritis. Nat. Rev. Immunol. 2, 527–535 (2002).
Cifuentes-Rius, A. et al. Inducing immune tolerance with dendritic cell-targeting nanomedicines. Nat. Nanotechnol. 16, 37–46 (2021).
Hilkens, C. & Isaacs, J. Tolerogenic dendritic cell remedy for rheumatoid arthritis: the place are we now? Clin. Exp. Immunol. 172, 148–157 (2013).
Zhang, B. et al. Website-specific PEGylation of interleukin-2 enhances immunosuppression through the sustained activation of regulatory T cells. Nat. Biomed. Eng. 5, 1288–1305 (2021).
Peng, B. et al. Tuned cationic dendronized polymer: molecular scavenger for rheumatoid arthritis remedy. Angew. Chem. Int. Ed. 58, 4254–4258 (2019).
Inglis, J. J. et al. Collagen‐induced arthritis as a mannequin of hyperalgesia: useful and mobile evaluation of the analgesic actions of tumor necrosis issue blockade. Arthritis Rheumatol. 56, 4015–4023 (2007).
Ruiz-Fernández, C. et al. WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytes. Lab. Make investments. 102, 989–999 (2022).
Barbi, J. et al. Metabolic management of the Treg/Th17 axis. Immunol. Rev. 252, 52–77 (2013).
Groux, H. et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737–742 (1997).
Desreumaux, P. et al. Security and efficacy of antigen-specific regulatory T-cell remedy for sufferers with refractory Crohn’s illness. Gastroenterology 143, 1207–1217 (2012).
Reife, R. A. et al. SWR mice are immune to collagen-induced arthritis however produce doubtlessly arthritogenic antibodies. Arthritis Rheumatol. 34, 776–781 (1991).
Bettelli, E. et al. Reciprocal developmental pathways for the era of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–238 (2006).
Korn, T. et al. IL-21 initiates an alternate pathway to induce proinflammatory TH17 cells. Nature 448, 484–487 (2007).
Sakaguchi, S. et al. Regulatory T cells and immune tolerance. Cell 133, 775–787 (2008).
Dobrovolskaia, M. A. & McNeil, S. E. Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2, 469–478 (2007).
Hoshyar, N., Grey, S., Han, H. & Bao, G. The impact of nanoparticle measurement on in vivo pharmacokinetics and mobile interplay. Nanomedicine 11, 673–692 (2016).
Madaan, A. et al. A stepwise process for isolation of murine bone marrow and era of dendritic cells. J. Biol. Strategies 1, 1–6 (2014).
Model, D. D., Latham, Ok. A. & Rosloniec, E. F. Collagen-induced arthritis. Nat. Protoc. 2, 1269–1275 (2007).
Gao, X. H. et al. A store-operated calcium channel inhibitor attenuates collagen-induced arthritis. Br. J. Pharmacol. 172, 2991–3002 (2015).
Schmitz, N., Laverty, S., Kraus, V. B. & Aigner, T. Fundamental strategies in histopathology of joint tissues. Osteoarthr. Cartil. 18, 113–116 (2010).
Kim, J. E. et al. Impact of self-assembled peptide-mesenchymal stem cell advanced on the development of osteoarthritis in a rat mannequin. Int. J. Nanomed. 9, 141–157 (2014).
